<![CDATA[I’ve had my fill of election returns. Here’s a set of numbers I was happy to read this week. In a small colon cancer trial, 14 patients whose tumors were already more likely to respond to immunotherapy got two experimental drugs before surgery. When the tissue came back from the lab, 13 of the 14 had no viable tumor left in the samples.]]>
Cancer Had a Bad Week, Too. Here’s Some News Worth Celebrating.
